mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-14 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
4e-13 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0002 |